EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi Malaria

Thanaporn Wattanakul iD, Daniel J Cooper iD, Katherine Plewes iD, Matthew J Grigg iD, Giri S Rajahram iD, Timothy William iD, Arjen M Dondorp iD, Michael D Edstein iD, Geoffrey W Birrell iD, Nicholas M Anstey iD, Richard M Hoglund iD, Bridget E Barber iD und 1 weitere

CPT: Pharmacometrics & Systems Pharmacology · 2026-07 · 15 (7)

DOI: 10.1002/psp4.70283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, online erschienen am 22.06.2026. Verfasst von Thanaporn Wattanakul und 12 weiteren Autor:innen. Beteiligte Einrichtung: Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Acetaminophen, Antimalarials, Malaria, Models, Biological. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paracetamol may improve renal function in patients with severe Plasmodium knowlesi malaria, particularly in those with acute kidney injury and hemolysis, via inhibition of cell‐free hemoglobin mediated oxidative kidney damage. We developed a population pharmacokinetic/pharmacodynamic (PK/PD) model to assess effects of paracetamol on creatinine, hepatotoxicity, fever clearance, and parasite clearance among Malaysian patients with predominantly non‐severe knowlesi malaria using data from the PACKNOW trial (Clinical Trials Registration: NCT03056391). A total of 372 patients were included in the PK/PD analyses (paracetamol: n = 183, control: n = 189). Paracetamol PK was described using a prior PK model published in patients with falciparum malaria. The PK/PD demonstrated that higher paracetamol exposures were associated with a faster decline in both creatinine and fever clearance time, supporting its renoprotective and antipyretic effects. Increased paracetamol exposure was not associated with hepatotoxicity or serious adverse events, despite a weak positive association with liver transaminases over time. No significant relationship was observed between paracetamol exposure and parasite clearance. Overall, these findings highlight an exposure‐response relationship for paracetamol and a decline in creatinine, supporting its use as a renoprotective drug in treating Plasmodium knowlesi malaria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenAntimalarialsMalariaModels, BiologicalPlasmodium knowlesiAdultFemaleHumansMaleMiddle AgedYoung AdultCreatinineMalaysiaClinical Trials, Phase III as TopicRandomized Controlled Trials as TopicMulticenter Studies as Topic

Stichwörter der Autor:innen

Plasmodium knowlesi malariaparacetamolpharmacodynamicspharmacokineticsrenoprotection

Substanzen

AcetaminophenAntimalarialsCreatinine

Autor:innen und Institutionen

  • Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
  • Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford University, Oxford, UK.
  • Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.
  • Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Sabah, Malaysia.
  • Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Thanaporn Wattanakul, Daniel J Cooper, Katherine Plewes, Matthew J Grigg, Giri S Rajahram, Timothy William, Arjen M Dondorp, Michael D Edstein, Geoffrey W Birrell, Nicholas M Anstey, Richard M Hoglund, Bridget E Barber, Joel Tarning

Zitieren

APA

Wattanakul, T., Cooper, D. J., Plewes, K., Grigg, M. J., Rajahram, G. S., William, T., Dondorp, A. M., Edstein, M. D., Birrell, G. W., Anstey, N. M., Hoglund, R. M., Barber, B. E., & Tarning, J. (2026). Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi Malaria. CPT: Pharmacometrics & Systems Pharmacology, 15(7). https://doi.org/10.1002/psp4.70283

Vancouver

Wattanakul T, Cooper DJ, Plewes K, Grigg MJ, Rajahram GS, William T, et al. Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi Malaria. CPT: Pharmacometrics & Systems Pharmacology. 2026;15(7). doi:10.1002/psp4.70283

BibTeX
@article{Wattanakul2026,
  author = {Wattanakul, Thanaporn and Cooper, Daniel J and Plewes, Katherine and Grigg, Matthew J and Rajahram, Giri S and William, Timothy and Dondorp, Arjen M and Edstein, Michael D and Birrell, Geoffrey W and Anstey, Nicholas M and Hoglund, Richard M and Barber, Bridget E and Tarning, Joel},
  title = {Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi Malaria},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2026},
  volume = {15},
  number = {7},
  doi = {10.1002/psp4.70283}
}
Kostenlos starten →